Anavex Nasdaq Delinquency Notification
Analysis based on 6 articles · First reported May 22, 2026 · Last updated May 22, 2026
The market may react negatively to Tiziana Life Sciences's stock due to the delinquency notification, as it signals potential compliance issues and risks of delisting from Nasdaq-100. Investors will monitor Tiziana Life Sciences's ability to file the Form 10-Q and submit a compliance plan by the deadline.
Tiziana Life Sciences received a delinquency notification from Nasdaq-100 on May 20, 2026, due to its failure to timely file its Form 10-Q for the quarter ended March 31, 2026. This indicates non-compliance with Nasdaq-100 Listing Rule 5250(c)(1). Tiziana Life Sciences has until July 20, 2026, to submit a plan to regain compliance. While this notification has no immediate effect on the company's stock, failure to resolve the issue could lead to delisting. Tiziana Life Sciences is a clinical-stage biopharmaceutical company focused on CNS disorders.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard